Chlortetracycline, a Novel Arf Inhibitor that Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells
Breast cancer is a major disease for women worldwide, where mortality is associated with tumour cell dissemination to distant organs. While the number of efficient anticancer therapies increased in the past 20 years, treatments targeting the invasive properties of metastatic tumour cells are still a...
Main Authors: | Eric Macia, Monserrat Vazquez-Rojas, Alessia Robiolo, Racha Fayad, Sophie Abélanet, Isabelle Mus-Veteau, Fabien Fontaine-Vive, Mohamed Mehiri, Frédéric Luton, Michel Franco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/4/969 |
Similar Items
-
Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens
by: Hubert Ziółkowski, et al.
Published: (2020-10-01) -
Characterization of Arf4GDP
by: Summerfeldt, Nathan
Published: (2010) -
On Partitions and Arf Semigroups
by: Tutaş Nesrin
Published: (2019-05-01) -
Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms
by: Herbert C. Morse III, et al.
Published: (2012-05-01) -
A specific monoclonal antibody for chlortetracycline detection in milk and honey samples based on ELISA
by: Panicha Poungmalai, et al.
Published: (2021-01-01)